Johnson and Johnson’s Ortho-McNeil-Janssen Pharmaceutical unit is still under fire in New Jersey state court this week, as closing arguments wrap-up regarding the risks associated with use of the company’s popular antibiotic, Levaquin. Specifically, plaintiffs allege that the J&J unit never fully warned patients of the serious risk for tendon damage associated with use of [...]
